144 related articles for article (PubMed ID: 29032611)
1. Fast IRMS screening of pseudoendogenous steroids in doping analyses.
de la Torre X; Colamonici C; Curcio D; Botrè F
Drug Test Anal; 2017 Nov; 9(11-12):1804-1812. PubMed ID: 29032611
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal evaluation of the isotope ratio mass spectrometric data: towards the 'isotopic module' of the athlete biological passport?
Jardines D; Botrè F; Colamonici C; Curcio D; Procida G; de la Torre X
Drug Test Anal; 2016 Nov; 8(11-12):1212-1221. PubMed ID: 27732769
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.
Miller GD; Nair V; Morrison MS; Summers M; Willick SE; Eichner D
Drug Test Anal; 2016 Nov; 8(11-12):1197-1203. PubMed ID: 27714988
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
5. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
[TBL] [Abstract][Full Text] [Related]
6. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
7. IRMS delta values (
Brailsford AD; Majidin WNM; Wojek N; Cowan DA; Walker C
Drug Test Anal; 2018 Nov; 10(11-12):1722-1727. PubMed ID: 30381908
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of longitudinal
de la Torre X; Jardines D; Botrè F
Drug Test Anal; 2022 Nov; 14(11-12):1877-1890. PubMed ID: 35738893
[TBL] [Abstract][Full Text] [Related]
9. GC-C-IRMS in routine doping control practice: 3 years of drug testing data, quality control and evolution of the method.
Polet M; Van Eenoo P
Anal Bioanal Chem; 2015 Jun; 407(15):4397-409. PubMed ID: 25503937
[TBL] [Abstract][Full Text] [Related]
10. Carbon isotope ratio mass spectrometry for detection of endogenous steroid use: a testing strategy.
Ahrens BD; Butch AW
Drug Test Anal; 2013 Jul; 5(7):534-40. PubMed ID: 23303562
[TBL] [Abstract][Full Text] [Related]
11. Changes in blood parameters after intramuscular testosterone ester injections - Implications for anti-doping.
Solheim SA; Mørkeberg J; Dehnes Y; Hullstein I; Juul A; Upners EN; Nordsborg NB
Drug Test Anal; 2020 Aug; 12(8):1019-1030. PubMed ID: 32307878
[TBL] [Abstract][Full Text] [Related]
12. Profiling of urinary steroids by gas chromatography-mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry.
Wang J; Wu M; Liu X; Xu Y
Steroids; 2011 Dec; 76(14):1560-5. PubMed ID: 21945895
[TBL] [Abstract][Full Text] [Related]
13. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
14. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
[TBL] [Abstract][Full Text] [Related]
15. Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine.
Casilli A; Piper T; de Oliveira FA; Padilha MC; Pereira HM; Thevis M; de Aquino Neto FR
Drug Test Anal; 2016 Nov; 8(11-12):1204-1211. PubMed ID: 27739243
[TBL] [Abstract][Full Text] [Related]
16. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
17. Implementation of AICAR analysis by GC-C-IRMS for anti-doping purposes.
Buisson C; Frelat C; Mongongu C; Martinat N; Audran M
Drug Test Anal; 2017 Nov; 9(11-12):1704-1712. PubMed ID: 29032594
[TBL] [Abstract][Full Text] [Related]
18. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of longitudinal steroid profiling with the ADAMS adaptive model for detection of transdermal, intramuscular, and subcutaneous testosterone administration.
Nair VS; Husk J; Miller GD; van Eenoo P; Crouch A; Eichner D
Drug Test Anal; 2020 Oct; 12(10):1419-1431. PubMed ID: 32578357
[TBL] [Abstract][Full Text] [Related]
20. Significant increase of salivary testosterone levels after single therapeutic transdermal administration of testosterone: suitability as a potential screening parameter in doping control.
Thieme D; Rautenberg C; Grosse J; Schoenfelder M
Drug Test Anal; 2013; 5(11-12):819-25. PubMed ID: 24167110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
